舒利迭治疗慢性阻塞性肺疾病临床疗效观察

目的:观察舒利迭治疗慢性阻塞性肺疾病(COPD)的疗效。方法:我院呼吸科就诊的COPD患者120例,随机分为治疗组和对照组。对照组给予常规治疗,治疗组在此基础上给予吸入舒利迭。结果:治疗组的总有效率显著高于对照组,两组疗效比较差异有显著性意义(P<0.01);治疗组的氧分压(PaO2)治疗后显著高于对照组(P<0.05);二氧化碳分压(PaCO2)则显著低于对照组(P<0.05);治疗组的FEV1、FVC治疗后显著高于对照组(P<0.05)。舒利迭无明显的毒副作用。结论:应用舒利迭治疗COPD在临床上能显著改善动脉血气指标,使用安全,值得在临床上推广。

Observation of the Clinical Therapeutic Effect of Seretide in Treating Chronic Obstructive Pulmonary Disease

Objective To investigate the effects of Seretide in the treatment of chronic obstructive pulmonary disease (COPD). Methods Respiratory department for treatment of 120 cases of COPD were randomly divided into treatment group and control group. The control group received conventional,the treatment group was given inhaled seretide on this basis. Results There was a significant difference between the two groups (P<0.01), the overall effective rate in treatment group significantly higher than in control group’s. After treatment PaO2 of the treatment group was significantly higher (P<0.05),PaCO2 was significantly lower than the control group (P<0.05). FEV1 and FVC of the treatment group was significantly higher than the control group (P<0.05). Seretide in the treatment of COPD was basically no obvious toxicity. Conclusion Seretide in the treatment of COPD can significantly improve arterial blood gases,it’s safety and worth promoting in clinic.